405 related articles for article (PubMed ID: 16932480)
1. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E
Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypercalcaemia with pamidronate in patients with end stage renal failure.
Davenport A; Goel S; Mackenzie JC
Scand J Urol Nephrol; 1993; 27(4):447-51. PubMed ID: 8159916
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of a hypercalcemic crisis in a myelomatous patient under chronic hemodialysis. The role of calcitonin].
Bissoli F; Simonati V; Volpini T; Novi C
Minerva Nefrol; 1980; 27(2):351-4. PubMed ID: 7219856
[No Abstract] [Full Text] [Related]
4. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
Sekine M; Takami H
Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
[TBL] [Abstract][Full Text] [Related]
6. Interpretation of hypercalcemia in a patient with end-stage renal disease.
Nora NA; Singer I
Arch Intern Med; 1992 Jun; 152(6):1321-2. PubMed ID: 1599363
[TBL] [Abstract][Full Text] [Related]
7. Managing the complications of plasma cell myeloma.
Cohen HJ; Rundles RW
Arch Intern Med; 1975 Jan; 135(1):177-84. PubMed ID: 122891
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation.
Attard TM; Dhawan A; Kaufman SS; Collier DS; Langnas AN
Pediatr Transplant; 1998 May; 2(2):157-9. PubMed ID: 10082449
[TBL] [Abstract][Full Text] [Related]
10. Hypercalcemic crisis successfully treated with prompt calcium-free hemodialysis.
Wang CC; Chen YC; Shiang JC; Lin SH; Chu P; Wu CC
Am J Emerg Med; 2009 Nov; 27(9):1174.e1-3. PubMed ID: 19931789
[TBL] [Abstract][Full Text] [Related]
11. Hypercalcemia associated with tertiary hyperparathyroidism managed conservatively with pamidronate in a hemodialysis patient.
Czosnowski LM; Hudson JQ; Canada RB
Am J Med Sci; 2009 Apr; 337(4):300-1. PubMed ID: 19365180
[TBL] [Abstract][Full Text] [Related]
12. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy.
Johnson WJ; Kyle RA; Pineda AA; O'Brien PC; Holley KE
Arch Intern Med; 1990 Apr; 150(4):863-9. PubMed ID: 2183734
[TBL] [Abstract][Full Text] [Related]
13. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
Culbert EC; Schfirin BS
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):789-91. PubMed ID: 17018504
[TBL] [Abstract][Full Text] [Related]
14. Secretion of parathyroid hormone-related peptide in patients with multiple myeloma.
Beaudreuil J; Cohen-Solal M; Doré MX; Vernejoul MC; Bardin T; Celton N; Giraudeaux V; Kuntz D
Rev Rhum Engl Ed; 1996; 63(7-8):502-3. PubMed ID: 8896065
[TBL] [Abstract][Full Text] [Related]
15. [Maintenance hemodialysis in IgD- lambda -type multiple myeloma associated with severe renal failure].
Kihara M; Ikeda Y; Shibata K; Masumori S; Ebira H
Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):177-81. PubMed ID: 8139151
[TBL] [Abstract][Full Text] [Related]
16. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
[TBL] [Abstract][Full Text] [Related]
17. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.
Lee DC; Lee GY
J Toxicol Clin Toxicol; 1998; 36(7):719-21. PubMed ID: 9865241
[TBL] [Abstract][Full Text] [Related]
18. [Use of diphosphonates in the treatment of hypercalcemia in multiple myeloma: efficacy of 4-amino-hydroxybutylidene-1,1-bisphosphonate (AHButBP)].
Attardo-Parrinello G; Crema F; Merlini G; Spaghi A; Fiorentini ML
Medicina (Firenze); 1988; 8(1):75-6. PubMed ID: 3226251
[No Abstract] [Full Text] [Related]
19. Reply. Kastritis E. et al. Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone containing regimes and the impact of novel agents. Haematologica 2007; 92:546-9.
Bergner R; Hoffmann M; Uppenkamp M
Haematologica; 2008 Jan; 93(1):e18-9. PubMed ID: 18166771
[No Abstract] [Full Text] [Related]
20. [Plasmapheresis treatment in multiple myeloma with kidney insufficiency].
Blumberg A; Bürgi W; Marti HR
Schweiz Med Wochenschr; 1983 Mar; 113(11):398-402. PubMed ID: 6844898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
